Published in J Clin Oncol on June 01, 1998
Second cancers following pediatric Hodgkin's disease. J Clin Oncol (1998) 3.19
Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol (1996) 2.44
Estimation of oxygen delivery in newborns with a univentricular circulation. Circulation (1998) 2.26
The evolution of alpha-fetoprotein and albumin. I. A comparison of the primary amino acid sequences of mammalian alpha-fetoprotein and albumin. J Biol Chem (1981) 1.77
A national syndromic surveillance system for England and Wales using calls to a telephone helpline. Euro Surveill (2006) 1.66
Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells. J Exp Med (1991) 1.55
Bazex syndrome (acrokeratosis paraneoplastica). An analytic review. Medicine (Baltimore) (1991) 1.49
Impact of non-CTCL dermatologic diagnoses and adjuvant therapies on cutaneous T-cell lymphoma patients treated with total skin electron beam radiation therapy. Int J Radiat Oncol Biol Phys (1994) 1.44
High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease. Ann Oncol (2000) 1.43
Priapism in sickle cell disease: possible contributory effect of cocaine use. Arch Intern Med (1993) 1.39
Alternative splicing of CD44 pre-mRNA in human colorectal tumors. Biochem Biophys Res Commun (1994) 1.18
Clinical pharmacology and safety evaluation of Timentin. Am J Med (1985) 1.12
Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. J Clin Oncol (2004) 1.10
Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. J Clin Oncol (1996) 1.07
Lack of reactivity to CMV pp65 antigenemia testing in a patient with CMV disease following allogeneic bone marrow transplant. Bone Marrow Transplant (1998) 1.06
Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1. J Biol Chem (1994) 1.05
Degradation rates of acetylcholine receptors can be modified in the postjunctional plasma membrane of the vertebrate neuromuscular junction. J Cell Biol (1986) 1.03
The Copper T 220C: a new long-acting copper intrauterine contraceptive device. Am J Obstet Gynecol (1976) 0.99
Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients. Clin Exp Immunol (2012) 0.95
Adhesive interactions between alternatively spliced CD44 isoforms. J Biol Chem (1995) 0.94
Temocillin concentrations in human tissues. Drugs (1985) 0.93
The variant mRNA isoform of human metastasis gene (CD44V) detected in the cell lines of human hepatocellular carcinoma. Biochem Mol Biol Int (1994) 0.93
CD44V6 expression in human colorectal carcinoma. Hum Pathol (1998) 0.92
Patient/caregiver-reported recombinant factor VIIa (rFVIIa) dosing: home treatment of acute bleeds in the Dosing Observational Study in Hemophilia (DOSE). Haemophilia (2011) 0.91
RNA synthesis in myeloma cells synchronized by isoleucine starvation. Nucleic Acids Res (1978) 0.91
Use of rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation. Bone Marrow Transplant (1999) 0.89
Use of recombinant activated factor VII in patients with Glanzmann's thrombasthenia: a review of the literature. Haemophilia (2014) 0.86
Thyroid lymphoma. The case for combined modality therapy. Cancer (1994) 0.86
Gonorrhea screening program in a women's hospital outpatient department: results and analysis of risk factors. J Am Vener Dis Assoc (1976) 0.85
Dermatomyositis and lichen myxedematosus. A clinical, histopathological and electron microscopic study. Dermatologica (1973) 0.85
Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients. Antimicrob Agents Chemother (1983) 0.84
Haemophilia Experiences, Results and Opportunities (HERO) Study: survey methodology and population demographics. Haemophilia (2013) 0.84
Haemophilia Experiences, Results and Opportunities (HERO) Study: influence of haemophilia on interpersonal relationships as reported by adults with haemophilia and parents of children with haemophilia. Haemophilia (2014) 0.84
Comparative analysis of three nucleic acid-based detection systems for hepatitis C virus RNA in plasma from liver transplant recipients. Mol Cell Probes (1996) 0.84
Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX. Haemophilia (2011) 0.84
A phase II study of outpatient chemotherapy with cisplatin, 5-fluorouracil, and leucovorin in nasopharyngeal carcinoma. Cancer (1994) 0.84
Toxic erythema of chemotherapy following i.v. BU plus fludarabine for allogeneic PBSC transplant. Bone Marrow Transplant (2012) 0.82
Varicella-zoster virus infections after autologous bone marrow transplantation in children. Bone Marrow Transplant (1989) 0.82
Acyclovir-resistant chronic cutaneous herpes simplex in Wiskott-Aldrich syndrome. Br J Dermatol (1995) 0.82
A phase I study of paclitaxel for mobilization of peripheral blood progenitor cells. Bone Marrow Transplant (1999) 0.82
Screening recombinant DNA libraries: a rapid and efficient method for isolating cDNA clones utilizing the PCR. Biotechniques (1991) 0.81
The multispecific cell adhesion molecule CD44 is represented in reticulocyte cDNA. Biochem Biophys Res Commun (1991) 0.81
Pharmacokinetics of ticarcillin and clavulanic acid (timentin) in relation to renal function. Antimicrob Agents Chemother (1986) 0.81
Assessing the impact of age, race, ethnicity and inhibitor status on functional limitations of patients with severe and moderately severe haemophilia A. Haemophilia (2011) 0.80
Patient- and caregiver-reported bleeding symptoms and reasons for starting and stopping treatment with recombinant factor VIIa: analysis of the Dosing Observational Study in Haemophilia (DOSE). Haemophilia (2012) 0.80
Neutropenic infections in 100 patients with non-Hodgkin's lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: out-patient treatment is a viable option. Bone Marrow Transplant (1999) 0.80
Familial macroglobulinemia in a Lebanese family with two sisters presenting Waldenström's disease. Acta Oncol (1991) 0.80
Can scoring influence athletic performance? Sex and the athlete. J Am Coll Health Assoc (1975) 0.80
U.S. survey of surgical capabilities and experience with surgical procedures in patients with congenital haemophilia with inhibitors. Haemophilia (2011) 0.80
Hyperleukocytosis and retinal hemorrhages after chemotherapy and Filgrastim administration for peripheral blood progenitor cell mobilization. Bone Marrow Transplant (1998) 0.79
Recognizing otolaryngologic symptoms in patients with temporomandibular disorders. Cranio (1993) 0.79
Electromyography of masticatory muscles in craniomandibular disorders. Laryngoscope (1991) 0.79
DNA fingerprinting of crude bacterial lysates using degenerate RAPD primers. PCR Methods Appl (1995) 0.79
Assessment of cardiac and pulmonary function in adult patients with Hodgkin's disease treated with ABVD or MOPP/ABVD plus adjuvant low-dose mediastinal irradiation. Cancer Invest (1999) 0.79
Alternatively spliced CD44 isoforms containing exon v10 promote cellular adhesion through the recognition of chondroitin sulfate-modified CD44. Exp Cell Res (1999) 0.79
Prognostic significance of CD44 expression in adenocarcinoma of the lung. Clin Mol Pathol (1995) 0.79
Haemophilia Experiences, Results and Opportunities (HERO) study: treatment-related characteristics of the population. Haemophilia (2014) 0.79
Randomized comparative study of the copper T 300, Dalkon shield, and Shell Loop in parous women. Obstet Gynecol (1975) 0.78
Myofacial pain dysfunction: analysis of 476 patients. Laryngoscope (1986) 0.78
Burkitt's lymphoma-leukemia in patients treated for Hodgkin's disease. Cancer Invest (1996) 0.78
P-glycoprotein expression and multidrug resistance in cutaneous T-cell lymphoma. Cancer Invest (2000) 0.78
Polyadenylation of RNA in a cell-free system from mouse myeloma cells. J Biol Chem (1978) 0.78
Retention of CD44 introns in bladder cancer: understanding the alternative splicing of pre-mRNA opens new insights into the pathogenesis of human cancers. J Pathol (1995) 0.78
Primary gastrointestinal lymphomas. Gastroenterologist (1996) 0.78
Enzymatic and molecular diagnosis of Gaucher disease. Clin Lab Med (1995) 0.78
Detection and viability of tumor cells in peripheral blood stem cell and bone marrow collections from breast cancer patients. Blood (1994) 0.78
Chlorambucil-induced seizures. Cancer (1997) 0.78
A simplified approach to stem cell mobilization in multiple myeloma patients not previously treated with alkylating agents. Bone Marrow Transplant (2003) 0.78
Second solid malignancies after combined modality therapy for Hodgkin's disease. J Clin Oncol (1995) 0.78
Health-related quality of life in haemophilia patients with inhibitors and their caregivers. Haemophilia (2012) 0.78
Childhood malignant lymphoma of bone. Med Pediatr Oncol (1991) 0.77
Interleukin-5 mRNA in three T-cell lymphomas with eosinophilia. Am J Hematol (1993) 0.77
Comparison of three different models of the copper T intrauterine contraceptive device. Am J Obstet Gynecol (1979) 0.77
Molecular mechanisms regulating the hyaluronan binding activity of the adhesion protein CD44. J Neurooncol (1995) 0.77
Differential expressions of CD44 variants in tumors affecting the central nervous system. Mol Diagn (1999) 0.77
Salvage chemotherapy in refractory germ cell tumors with etoposide (VP-16) plus ifosfamide plus high-dose cisplatin. A VIhP regimen. Cancer (1988) 0.76
[Value of high-dose chemotherapy followed by bone marrow autograft in non-seminomatous germinal tumor with poor prognosis. Results of the combination of cisplatinum, etoposide and cyclophosphamide (PEC protocol)]. Bull Cancer (1990) 0.76
Diffuse recurrent herpes simplex virus skin lesions after adequate therapy with vidarabine. Pediatr Infect Dis (1986) 0.76
Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients. J Clin Oncol (1997) 0.76
Editorial: Epileptics and contact sports. JAMA (1974) 0.76
Understanding the experience of caring for children with haemophilia: cross-sectional study of caregivers in the United States. Haemophilia (2014) 0.76
Re: Discordant pair analysis of rFVIIa and pd-aPCC response. Haemophilia (2011) 0.75
Application of the Cotswolds Criteria for the assessment of disease response in patients treated for Hodgkin's disease. J Clin Oncol (1995) 0.75
Radiation for early-stage Hodgkin's disease? J Clin Oncol (2000) 0.75
CHOP versus intensive regimens in non-Hodgkin's lymphoma. N Engl J Med (1993) 0.75
Multidisciplinary approach to the differential diagnosis of facial, head and neck pain. J Prosthet Dent (1991) 0.75
Nutrition in the athlete. Pa Med (1970) 0.75
Target isotope effects for vibrationally-resolved electron capture in low-energy collisions of O3+ with molecular hydrogen. Faraday Discuss (2004) 0.75
Nutrition in athletes. J Am Coll Health Assoc (1966) 0.75
Cardiac rhabdomyosarcoma. Conn Med (1988) 0.75
Restriction-fragment-length polymorphisms of 5'-flanking region of insulin I gene in BB and other rat strains. Absence of association with IDDM. Diabetes (1987) 0.75
Nabumetone pharmacokinetics in patients with varying degrees of renal impairment. Am J Med (1987) 0.75
The response of parathyroid hormone to specific changes in either ionized calcium, ionized magnesium, or protein-bound calcium in humans. Metabolism (1991) 0.75
Atrophie blanche in a patient with gamma-heavy-chain disease. Arch Dermatol (1991) 0.75